Product Information
LAMOTRIGINE ER 250 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $1.3008 per EA under NDC 00228163803. Its NADAC has been published 485 times since Mar 15, 2017.
Strength
250 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228163803
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA200672On Market Since
6/1/2016
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ER 250 MG TABLET has been published 485 times since Mar 15, 2017, and over the history we have for it it has declined 89.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3008 per EA |
|---|---|
| All-time high | $12.7259 (Mar 15, 2017) |
| All-time low | $1.1070 (Nov 19, 2025) |
| 52-week high | $1.3201 |
| 52-week low | $1.1070 |
| Median price | $5.8642 |
| Average price | $5.9085 |
| Largest weekly change | +56.5% (Aug 21, 2024) |
| Weeks tracked | 485 |
| Tracking since | Mar 15, 2017 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ER 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 250 MG TABLET, manufactured by Actavis Pharma, Inc., is $1.3008 per EA (NDC 00228163803), effective Jun 24, 2026.
How has the price of LAMOTRIGINE ER 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ER 250 MG TABLET has declined 89.8%. It has been tracked across 485 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 250 MG TABLET?
Since Mar 15, 2017, the NADAC for LAMOTRIGINE ER 250 MG TABLET has ranged from a low of $1.1070 (Nov 19, 2025) to a high of $12.7259 (Mar 15, 2017), with a median of $5.8642 per EA.
Are there cheaper alternatives to LAMOTRIGINE ER 250 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as LAMOTRIGINE ER 250 MG TABLET, but none are currently priced below it.
Who manufactures LAMOTRIGINE ER 250 MG TABLET?
LAMOTRIGINE ER 250 MG TABLET (NDC 00228163803) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification